Hims & Hers stands to gain if the FDA loosens restrictions on peptides - Reuters
Hims & Hers stands to gain if the FDA loosens restrictions on peptides Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQWTBBQUZOR1c4RTZSV3JnU0RnTXVodU8yTERqcTFidGRnSHdVUExadDdjcm9hNU9MZVlwVjNKTUhwR1loTTlFLVNLODB2SEtCaXlHUl9OSUg2Y2k2VDFpZUdqTk1oXzZhak45cnlJZVdUSTRLZmdXM05oU1c0ay1KbnYtc2JSa2I5NE9lLWhVODN5a1lSVElqeUNqSEd3cnRnS0s5eGpiMXljZW0wU3B6dw?oc=5" target="_blank">Hims & Hers stands to gain if the FDA loosens restrictions on peptides</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies - Reuters
PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies Reuters
October 7, 2026 at 11:36 AMWHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMEXCLUSIVE: US consumer watchdog examiners adopt lighter touch amid pressure and threats, sources say - Reuters
EXCLUSIVE: US consumer watchdog examiners adopt lighter touch amid pressure and threats, sources say Reuters
October 7, 2026 at 10:51 AMHalozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PM